Home >
Medicine Info >
Montaz 1 g Injection
Loading interface...

Montaz 1 g Injection

Manufactured byARISTO PHARMACEUTICALS PVT LTD
ContainsCeftriaxone (1000 mg) + Tazobactam (125 mg)
Description
Montaz 1 g Injection is a combination medicine consists of Ceftriaxone and Tazobactam. It is an antibiotic used to treat bacterial infections affecting the lungs, nose, throat, skin, urinary tract, etc. It is also used to prevent infections at surgical sites. This medicine works by interfering in the formation of the bacterial cell wall and eventually kills them. Montaz 1 g Injection is not effective against infections caused by viruses. Montaz 1 g Injection may cause side effects like diarrhoea, pain at the injection site, headache, weakness. Contact your doctor if any side effects are seen for a longer period. Avoid driving a vehicle or operating a machine after administration of Montaz 1 g Injection as it may cause dizziness or drowsiness and may affect your vision. Do not use this medicine if you are previously allergic to it. Montaz 1 g Injection should not be self administrated. It will be administered into your vein or muscle by a health care professional in a hospital or clinical setting. Your doctor will determine the number of doses and how often the injections should be given based on your condition. Once an antibiotic is started, it is always recommended to finish the entire course of treatment. Montaz 1 g Injection may not be suitable for all people. Inform your doctor if you have any liver, kidney, or stomach and intestinal disease before taking the medicine. Montaz 1 g Injection may interact with calcium-containing products. Hence, avoid taking products like milk or curd that contains calcium. This medicine may be safe for use in pregnancy. Hence, it is recommended to inform your doctor if you are pregnant, or are breastfeeding before prescribing this medicine to you.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Montaz 1 g Injection

  • Nausea
  • Vomiting
  • Black or tarry stools
  • Chest pain
  • Fever
  • Difficulty or painful urination
  • Sore throat
  • Diarrhoea
  • Abdominal pain
  • Dizziness
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Acid or sour stomach
  • Change in taste
  • Excessive air or gas in stomach

Uses of Montaz 1 g Injection

What is it prescribed for?

  • Bacterial infections
  • Lower respiratory tract infection
  • Intra-abdominal Infection
  • Surgical prophylaxis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effects of Montaz 1 g Injection starts within 10-15 minutes after the intravenous or intramuscular administration.
  • How long do the effects of this medicine last?
    The effect of Montaz 1 g Injection lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Montaz 1 g Injection.
  • Can this medicine be taken during pregnancy?
    Montaz 1 g Injection may be safe in pregnancy to treat bacterial infections. It is not known to cause birth defects when taken by pregnant women. Your doctor may prescribe this medicine if the benefits outweigh the risks.
  • Can this medicine be taken while breast-feeding?
    It is not known if Montaz 1 g Injection passes into the breastmilk or not. Hence, it is not recommended for use while breastfeeding. Consult your doctor before using this medicine. If you are prescribed this medicine while you are breastfeeding, your infant will be monitored for any undesired effects like diarrhoea or rashes.

Allergy

Avoid using Montaz 1 g Injection if you are allergic to it. Inform your doctor if there is any history of allergy to this medicine. If you notice any symptoms such as skin rash, itching/swelling (face, lips, tongue), dizziness, breathing difficulty, etc., inform your doctor and seek immediate medical attention.

Lidocaine

Montaz 1 g Injection should not be given in people receiving lidocaine as a solvent for intravenous injection or infusion. However, lidocaine can be used as a solvent for the intramuscular route of injection for this medicine.

Calcium-containing products

Do not administer Montaz 1 g Injection in neonates (≤ 28 days) who are receiving calcium-containing intravenous solutions or infusions such as parenteral nutrition. This medicine may precipitate along with calcium in the lungs and kidneys.
Warnings for special population

Pregnancy

Montaz 1 g Injection may be safe in pregnancy to treat bacterial infections. It is not known to cause birth defects when taken by pregnant women. Your doctor may prescribe this medicine if the benefits outweigh the risks.

Breast-feeding

It is not known if Montaz 1 g Injection passes into the breastmilk or not. Hence, it is not recommended for use while breastfeeding. Consult your doctor before using this medicine. If you are prescribed this medicine while you are breastfeeding, your infant will be monitored for any undesired effects like diarrhoea or rashes.
General warnings

Hemolytic anemia

Immune-mediated hemolytic anaemia has been reported in patients receiving Montaz 1 g Injection. Discontinue the medicine if you develop hemolytic anaemia until the exact cause is determined.

Prothrombin time

There may be alterations in prothrombin time (a test used to check for bleeding problems) while receiving Montaz 1 g Injection. Regular monitoring of prothrombin time may be necessary, especially in patients with low vitamin K levels, malnutrition, or patients with liver diseases.

Antibiotic resistance

Antibiotic resistance occurs when bacteria develop the ability to defeat the medicine that was intended to kill them. Hence, to avoid such resistance you should always complete the entire course of treatment with Montaz 1 g Injection even if you feel better after receiving a few doses.

Liver disease

Regular monitoring of the liver enzyme levels is necessary while administering Montaz 1 g Injection and even after treatment with this medicine is completed as this medicine may increase the levels of the liver enzymes.

Diarrhoea

Montaz 1 g Injection can cause diarrhoea because it may also kill the helpful bacteria in your stomach or intestine. Inform your doctor if you experience severe diarrhoea while receiving this medicine.

Use in neonates

Montaz 1 g Injection is not recommended for use in neonates less than 28 days of age since the safety and efficacy of use are not clinically established.

Administration

When used intravenously, Montaz 1 g Injection should be infused over a duration of at least 30 to 60 minutes. When used intramuscularly, the medicine should be injected over a duration of 2 to 4 minutes.

Driving or operating a machine

Montaz 1 g Injection may cause dizziness hence do not perform any activities such as driving a vehicle or operating a machine.

Missed Dose

Since Montaz 1 g Injection is administered in the hospital or clinical setting by a qualified healthcare professional, the chances of missing a dose are low.

Overdose

Since Montaz 1 g Injection is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by your doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amikacin

Ethinyl Estradiol

Cholera Vaccine

Cyclosporine

Probenecid

Entecavir

Disease interactions

Gastrointestinal diseases

Montaz 1 g Injection can kill the helpful bacteria in your stomach or intestine and leads to diarrhoea. Therefore use this medicine with extreme caution if you have any stomach or intestinal diseases, particularly colitis (inflammation of the large intestine), as it may worsen your health condition.

Seizure disorders

Seizure disorder is a condition due to uncontrolled electrical activity between brain cells that causes temporary abnormalities in muscle tone and movements, behaviour, etc. Avoid using Montaz 1 g Injection or maintain caution if you have any seizure episodes, as it can worsen your health condition. Your doctor may adjust the dose of this medicine if required.
Food interactions
Information not available.
Lab interactions

Direct Coombs test

The direct Coombs test finds antibodies attached to your red blood cells. A false-positive result may be obtained if this test is performed while receiving Montaz 1 g Injection.

Urine Glucose

A false-positive result for the urine glucose test may be obtained if this test is performed while receiving Montaz 1 g Injection. Your doctor may advise an alternative test to evaluate glucose levels.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Montaz 1 g Injection is for parenteral use. You should not administer it on your own. It should be administered by a qualified healthcare professional in a clinical or hospital setting. Your doctor will determine an appropriate dose of this injection based on your clinical condition. Report any undesirable side effects to your doctor promptly. Tell your doctor about all your current medicines as well as your medical conditions before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
Montaz 1 g Injection is a combination of Ceftriaxone and Tazobactam. Ceftriaxone works by preventing the formation of bacterial cell walls. This helps in stopping the growth and multiplication of the microorganism, eventually killing it. Tazobactam inhibits some chemicals produced by the bacteria and makes the bacteria more sensitive to ceftriaxone activity.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Third generation cephalosporins, Beta-lactamase inhibitors

Schedule

Schedule H

CiplaMed. 2021. CEFBACT T Injection. [online] Available at: < [Accessed 1 June 2021].

https://ciplamed.com/content/cefbact-t-injection>

Neisslabs.com. 2021. – Glicef-T (Ceftriaxone + Tazobactam 1.125 g Injection). [online] Available at: < [Accessed 1 June 2021].

http://neisslabs.com/pharma-product/glicef-t-ceftriaxone-tazobactam/>

Pubchem.ncbi.nlm.nih.gov. 2021. Tazobactam. [online] Available at: < [Accessed 1 June 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Tazobactam>

Pubchem.ncbi.nlm.nih.gov. 2021. Ceftriaxone. [online] Available at: < [Accessed 1 June 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Ceftriaxone>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Aug 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.